🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 15 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
20/10/2014 21,88 23,26 21,79 22,83 +2,75% 6,72% 1.039.600
17/10/2014 24,74 24,95 22,16 22,22 -0,36% 11,28% 3.908.200
16/10/2014 20,13 22,50 20,00 22,30 +6,65% 12,42% 2.473.800
15/10/2014 19,09 21,10 18,84 20,91 +10,58% 11,84% 1.973.400
14/10/2014 18,86 19,75 18,05 18,91 +1,61% 9,01% 1.200.600
13/10/2014 18,75 19,29 17,54 18,61 -0,85% 9,33% 2.137.700
10/10/2014 19,69 19,93 18,65 18,77 -5,44% 6,50% 1.302.200
09/10/2014 21,02 21,02 19,59 19,85 -4,98% 6,80% 1.440.900
08/10/2014 20,88 21,23 19,66 20,89 -0,24% 7,52% 1.704.400
07/10/2014 21,61 22,08 20,85 20,94 -4,08% 5,69% 1.079.700
06/10/2014 23,54 23,63 21,66 21,83 -6,31% 8,37% 1.963.000
03/10/2014 21,95 23,75 21,66 23,30 +7,72% 9,52% 2.200.800
02/10/2014 21,66 21,93 20,55 21,63 -1,14% 6,37% 1.953.400
01/10/2014 22,25 22,97 21,40 21,88 +3,70% 7,06% 3.608.400
30/09/2014 21,72 21,84 20,71 21,10 -1,77% 5,20% 1.409.800
29/09/2014 21,24 21,87 21,11 21,48 -1,87% 3,58% 671.600
26/09/2014 22,20 22,20 21,28 21,89 -0,91% 4,14% 599.700
25/09/2014 21,90 22,29 20,91 22,09 +0,50% 6,30% 1.010.600
24/09/2014 21,50 22,13 20,83 21,98 +6,65% 6,05% 1.186.900
23/09/2014 20,79 21,59 20,59 20,61 -0,87% 4,81% 970.900
22/09/2014 21,61 22,17 20,41 20,79 -4,55% 8,14% 1.006.800
19/09/2014 22,70 22,70 21,36 21,78 -3,33% 5,90% 1.392.400
18/09/2014 23,06 23,06 22,31 22,53 -1,79% 3,25% 525.400
17/09/2014 22,41 23,21 22,21 22,94 +2,87% 4,46% 653.600
16/09/2014 22,67 22,67 22,03 22,30 -1,85% 2,82% 667.500
15/09/2014 23,59 23,70 22,21 22,72 -4,46% 6,32% 1.034.900
12/09/2014 23,71 23,80 23,21 23,78 +0,04% 2,49% 757.000
11/09/2014 23,34 23,98 23,11 23,77 +1,02% 3,73% 665.200
10/09/2014 22,46 23,68 22,38 23,53 +5,14% 5,79% 901.400
09/09/2014 23,40 23,52 22,35 22,38 -3,16% 5,00% 737.000